Eupry

Eupry Competitive Intelligence & Landscape

eupry.com ·

Overview

Eupry Overview

Eupry is a Danish technology company founded in 2014 and headquartered in Copenhagen, Denmark. It specializes in providing digital solutions and IoT-based temperature monitoring systems designed for compliance in highly regulated industries such as pharmaceuticals, biotech, and healthcare logistics (eupry.com, tracxn.com). The company's core products include a GxP-compliant platform for temperature mapping, monitoring, and calibration, which helps organizations ensure the proper storage of sensitive assets like vaccines and medicines (eupry.com).

Eupry’s mission is to automate and digitalize temperature compliance processes, reducing waste of resources and time while enhancing safety and quality control in the distribution of critical healthcare products. The company employs over 60 staff members and has a global customer base of more than 1,000 clients, including major pharmaceutical companies like Novo Nordisk, AstraZeneca, and others (eupry.com, tracxn.com). Its value proposition centers on providing reliable, scalable, and user-friendly compliance solutions that improve operational efficiency and support global health initiatives, such as vaccine distribution during the COVID-19 pandemic (thehub.io).

Competitors

Eupry Competitors

Eupry operates in the field of temperature monitoring solutions, primarily targeting industries that require strict compliance with regulatory standards, such as pharmaceuticals, food, and biotech sectors (Tracxn). Its key differentiators include its focus on real-time data collection, cloud-based platform, and automated alerts, which set it apart from traditional manual monitoring methods. Compared to competitors, Eupry emphasizes ease of use and integration with existing compliance workflows, aiming to provide a cost-effective alternative to more complex systems (Tracxn).

In terms of market positioning, Eupry is positioned as a scalable, user-friendly solution suitable for small to medium-sized enterprises, contrasting with larger, more feature-rich platforms like Crayon or Klue, which target enterprise clients with broader competitive intelligence needs (RivalSift). While Eupry’s pricing details are not explicitly listed, it is likely more affordable than high-end competitors, aligning with its focus on accessible, straightforward solutions for regulated industries. Its market share is growing steadily within niche sectors, driven by its compliance-centric features and ease of deployment.

Alternatives

Eupry Alternatives

Product & Pricing

Eupry Product and Pricing Intelligence

Eupry offers specialized temperature monitoring solutions primarily focused on regulated industries such as pharmaceuticals, biotech, and healthcare logistics. Their platform is cloud-native, built specifically for GxP compliance, and features patented ALIIO calibration technology that allows on-the-wall sensor calibration, significantly reducing calibration time (leadiq).

Regarding pricing, specific plans and tiers for Eupry are not explicitly detailed in the available search results. However, Eupry provides a free downloadable product catalog that includes technical specifications and solution options, indicating a tiered approach with different features and capabilities (eupry). The company emphasizes scalable, automated, and compliance-focused solutions, which suggests a range of offerings tailored to different customer needs, from basic monitoring to advanced, integrated systems.

Recent developments highlight Eupry’s significant funding, with a recent $24 million Series A round, supporting its growth and market expansion. Their solutions are designed to simplify manual processes, reduce errors, and ensure regulatory compliance, making them attractive for large-scale pharmaceutical and healthcare organizations seeking reliable temperature monitoring (leadiq). While detailed pricing plans and feature distinctions are not publicly listed, Eupry’s focus on compliance and automation positions it as a premium provider in the temperature monitoring market.

Hiring & Layoffs

Eupry Hiring and Layoffs

As of March 2026, Eupry has demonstrated a strong growth trajectory characterized by significant funding and strategic expansion efforts. The company secured over DKK 170 million in Series A funding in December 2024, which is a substantial investment aimed at scaling its international presence, particularly in the U.S. market (Kromann Reumert). This funding round underscores investor confidence and positions Eupry as a key player in the digital temperature compliance industry, especially within regulated sectors like pharma, biotech, and logistics (Leadiq).

Regarding hiring trends, Eupry continues to expand its team, with recent job postings for roles such as Chief Technology Officer, Revenue Operations Analyst, and Customer Relation Specialist in Copenhagen, indicating ongoing recruitment to support its growth and innovation initiatives (Life Science Talent Hub). The company’s hiring pattern suggests a focus on strengthening its technological and operational capabilities to enhance its market leadership and product offerings. Notably, the company has not publicly reported layoffs, which aligns with its growth-oriented strategy and recent funding success, signaling a stable and expanding organizational structure (DailyRemote). Overall, Eupry’s hiring and funding patterns reflect a strategic focus on scaling operations, technological innovation, and market expansion.

Leadership

Eupry Management and Leadership Team

As of March 2026, Eupry is led by CEO Christian Elster Jacobsen, who has been actively involved in the company's leadership since its founding. The company is owned by Chr. Augustinus Fabrikker, with Louise Krogh Rindom serving as Chairman, a role she has held since 2024 (augustinusfabrikker.dk). The management team also includes Louise Hartmann-Kruckow as General Counsel, indicating a structured leadership with specialized roles (theorg.com). Recent leadership changes or notable hires at the C-suite level are not explicitly detailed in the available sources, but the company’s leadership appears stable and focused on growth in the temperature compliance and IoT monitoring sectors (tracxn.com). Eupry's strategic focus on innovation and compliance solutions is supported by its recent funding momentum, including a significant Series A round, which underscores its expanding leadership and market ambitions (leadiq.com). Overall, Eupry’s leadership team combines experienced industry professionals dedicated to advancing digital temperature monitoring solutions for healthcare and pharmaceutical logistics.

Financials

Eupry Financial Performance, Fundraising, M&A

Eupry has demonstrated strong financial growth and activity in recent years. In 2025, the company achieved a revenue of $7.2 million, reflecting consistent growth since its inception in 2014 and a team of 65 employees (Latka). The company's estimated annual revenue is approximately $31.7 million, with a total funding amount of around $35 million, indicating a solid financial foundation (Growjo).

In terms of fundraising, Eupry secured a significant Series A funding round of $24 million in December 2024, led by Chr. Augustinus Fabrikker, an investment firm associated with the Augustinus Foundation. This round also included participation from Ugly Duckling Ventures, EIFO, and Sagitta, highlighting strong investor confidence in its innovative temperature monitoring solutions (MergerLinks).

Regarding M&A activity, there are no publicly available records of acquisitions involving Eupry as of March 2026. The company's recent growth, funding, and revenue figures suggest a healthy financial position and a focus on expanding its market presence in the cold chain and temperature monitoring industry (Tracxn). Overall, Eupry appears to be a financially robust company with active investor backing and significant revenue growth.

Partnerships

Eupry Partnerships, Clients and Vendors

Eupry has established notable partnerships and collaborations within the pharmaceutical and healthcare logistics sectors. One significant partnership is with Atos, announced in December 2020, where they collaborated to develop a Vaccine Logistics Monitoring as-a-Service solution to ensure compliance during the large-scale distribution of Covid-19 vaccines, particularly addressing temperature control and environmental monitoring across complex supply chains (Atos).

In terms of enterprise clients, Eupry counts over 1,000 customers worldwide, including major pharmaceutical companies such as Novo Nordisk, AstraZeneca, and Agilent Technologies, as well as logistics giants like DHL and FedEx. These clients rely on Eupry's IoT temperature monitoring solutions for GxP compliance, calibration, and validation in regulated environments (Eupry, thehub.io).

Eupry’s ecosystem relationships extend to collaborations with research and development entities like DTU Vet and integration partners such as AWS, leveraging cloud-based platforms for scalable, compliant monitoring solutions. Their patented ALIIO calibration technology and cloud-native platform demonstrate a strategic focus on innovation and compliance, positioning Eupry as a key player within the pharma and biotech ecosystems (Compare Eupry).

Events

Eupry Event Participations

Eupry actively participates in various industry events to promote its compliance solutions. Notably, they host and participate in webinars focused on GxP compliance, temperature monitoring, and calibration processes. Their upcoming webinars include topics such as "How to pass FDA inspections" scheduled for March 19th, 2026, and a product update webinar on March 31st, 2026, which are designed to educate and engage industry professionals (eupry.com).

In addition to webinars, Eupry offers on-demand sessions, including a virtual launch of "Mastering Temperature Mapping" and discussions on AI in GxP, providing valuable insights into compliance practices (eupry.com). They also conduct specialized webinars like "How to eliminate the gaps in your temperature compliance process," aimed at helping organizations unify and optimize their monitoring, calibration, and mapping efforts (eupry.com).

While specific conferences and trade shows are not explicitly listed in the search results, Eupry’s engagement through these webinars and on-demand content indicates their active involvement in industry education and community building within the GxP compliance sector (eupry.com).

Frequently Asked Questions

Who are Eupry's main competitors in temperature monitoring?

Eupry competes with companies like iTrak, Aegis Temperature Monitoring, Thermo Fisher Scientific (Temperature Monitoring Solutions), and TempTRAK in the temperature monitoring space. These companies offer various solutions for industries requiring precise temperature control, such as pharmaceuticals, food, and healthcare.

What industries does Eupry primarily serve?

Eupry focuses on providing temperature monitoring solutions for highly regulated industries, including pharmaceuticals, biotech, healthcare logistics, and the food industry. These industries require strict compliance with regulatory standards and precise temperature control for their products.

How does Eupry ensure compliance with GxP regulations?

Eupry's platform is designed for GxP compliance, featuring patented ALIIO calibration technology that allows on-the-wall sensor calibration, reducing calibration time. Their solutions automate and digitalize temperature compliance processes, helping organizations reduce waste, improve safety, and maintain quality control.

What market signals indicate Eupry's future strategic moves?

Keep an eye on Eupry's hiring patterns, partnerships, and participation in industry events such as webinars focused on GxP compliance and temperature monitoring. Monitoring their job postings can reveal expansion plans or new technology focuses. ForesightIQ can automatically track these signals, alerting you to strategic changes before they are publicly announced.

What is Eupry's pricing strategy for its temperature monitoring solutions?

While specific pricing details are not publicly available, Eupry likely offers a tiered pricing approach based on features and capabilities. They provide a free product catalog indicating various solution options, ranging from basic monitoring to advanced, integrated systems. Their focus on compliance and automation suggests a premium positioning in the market.

Is Eupry currently hiring, and what roles are they seeking?

Yes, Eupry has been actively hiring, indicating a growth trajectory. Recent job postings include roles like Chief Technology Officer, Revenue Operations Analyst, and Customer Relation Specialist, primarily located in Copenhagen. This suggests a focus on strengthening their technological and operational capabilities.

How can I track Eupry's strategic moves and announcements?

You can track Eupry's strategic moves by monitoring their website for announcements, following their social media, and keeping an eye on industry news. You can also monitor their participation in webinars and events. A platform like ForesightIQ automates this process by monitoring Eupry's digital exhaust and surfacing strategic signals from job postings, website changes, and more.

How does Eupry compare to iTrak?

Both Eupry and iTrak offer solutions for temperature monitoring, but iTrak focuses more broadly on equipment and asset management. Eupry specializes in GxP-compliant temperature monitoring for regulated industries like pharmaceuticals and biotech, emphasizing ease of use and integration with existing compliance workflows.

What competitive intelligence sources are available for Eupry?

Competitive intelligence on Eupry can be gathered from various sources, including their website, press releases, job postings, and industry publications. You can also analyze their participation in webinars and events, as well as monitor their social media presence. Keep an eye on their partnerships and collaborations with other companies.

Who are Eupry's major clients?

Eupry serves over 1,000 clients worldwide, including major pharmaceutical companies like Novo Nordisk, AstraZeneca, and Agilent Technologies. They also work with logistics giants such as DHL and FedEx, providing temperature monitoring solutions for GxP compliance.

What partnerships has Eupry established?

Eupry has partnered with companies like Atos to develop Vaccine Logistics Monitoring as-a-Service. They also collaborate with research entities like DTU Vet and integrate with cloud platforms like AWS, demonstrating a focus on innovation and compliance in the pharmaceutical and healthcare logistics sectors.

What are Eupry's key product features?

Eupry's key product features include a cloud-native platform built for GxP compliance and patented ALIIO calibration technology. This technology allows on-the-wall sensor calibration, reducing calibration time and simplifying manual processes. They offer scalable, automated, and compliance-focused solutions for temperature monitoring.

Powered by ForesightIQ · Competitive intelligence from digital exhaust